C14orf37_3632451O06Rik Inhibitors
C14orf37_3632451O06Rik Inhibitors refers to a class of chemical compounds that are designed to target and inhibit the activity of a specific protein known as C14orf37_3632451O06Rik. This protein is encoded by the C14orf37_3632451O06Rik gene, and its function in the human body is still a subject of ongoing research. C14orf37_3632451O06Rik inhibitors are synthetic molecules or small organic compounds that have been developed to interact with this particular protein, modulating its activity in various ways.
The development of C14orf37_3632451O06Rik inhibitors is part of a broader effort in molecular biology and pharmacology to understand the function of different genes and their encoded proteins. By selectively inhibiting C14orf37_3632451O06Rik, researchers aim to elucidate its role in cellular processes, signaling pathways, or other molecular interactions. These inhibitors can be valuable tools in laboratory settings for conducting experiments that seek to uncover the biological functions of C14orf37_3632451O06Rik and its contributions to cellular physiology. In summary, C14orf37_3632451O06Rik inhibitors represent a category of chemical compounds that are specifically designed to target and modulate the activity of the C14orf37_3632451O06Rik protein, aiding researchers in their quest to unravel its biological significance and implications in various cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a kinase involved in cell growth and proliferation, which may be linked to the regulatory pathways of C14orf37. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which could disrupt downstream signaling cascades that C14orf37 might influence. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is part of the MAPK/ERK pathway that can intersect with cellular processes involving C14orf37. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially altering stress response pathways that C14orf37 may affect. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, possibly influencing inflammatory response and stress-related pathways linked with C14orf37. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A broad-spectrum PI3K inhibitor that can affect multiple signaling pathways, potentially including those associated with C14orf37. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Targets the Akt pathway, which can intersect with signaling pathways involving C14orf37. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits Protein Kinase C (PKC), which can modulate several signaling pathways that C14orf37 may be part of. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A pan-PKC inhibitor that could disrupt signaling pathways involving C14orf37. | ||||||
SL-327 | 305350-87-2 | sc-200685 sc-200685A | 1 mg 10 mg | $107.00 $332.00 | 7 | |
Inhibits MEK and could affect cellular processes that are potentially regulated by C14orf37. | ||||||